Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: ERN, ERP

KLA Corporation Reports Fiscal 2024 Third Quarter Results


MILPITAS, Calif., April 25, 2024 /PRNewswire/ -- KLA Corporation (NASDAQ: KLAC) today announced financial and operating results for its third quarter of fiscal year 2024, which ended on March 31, 2024, and reported GAAP net income of $601.5 million and GAAP earnings per diluted share of $4.43 on revenue of $2.36 billion.

"KLA's March quarter results were above our adjusted guidance as customer demand and company execution tracked consistent with our expectations," said Rick Wallace, president and CEO, KLA Corporation. "As we have highlighted over the past few quarters, market conditions have stabilized and we expect our business levels to improve as we progress through the year. We are encouraged by the improvement in our customers' businesses across multiple end markets and this improvement is translating into constructive discussions with our customers about future opportunities for leading edge capacity investments."

GAAP Results


Q3 FY 2024

Q2 FY 2024

Q3 FY 2023

Total Revenue

$2,360 million

$2,487 million

$2,433 million

Net Income Attributable to KLA

$602 million

$583 million

$698 million

Net Income per Diluted Share Attributable to KLA

$4.43

$4.28

$5.03





Non-GAAP Results


Q3 FY 2024

Q2 FY 2024

Q3 FY 2023

Net Income Attributable to KLA

$715 million

$839 million

$761 million

Net Income per Diluted Share Attributable to KLA

$5.26

$6.16

$5.49

A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements included in this release. KLA will discuss the results for its fiscal year 2024 third quarter, along with its outlook, on a conference call today beginning at 3 p.m. PT. A webcast of the call will be available at: www.kla.com

Fourth Quarter Fiscal 2024 Guidance

The following details our guidance for the fourth quarter of fiscal 2024 ending in June:

For additional details and assumptions underlying our guidance metrics, please see the company's published Letter to Shareholders, Earnings Slide Presentation and Earnings Infographic on the KLA investor relations website. Such Letter to Shareholders, Earnings Slide Presentation and Earnings Infographic are not incorporated by reference into this earnings release.

About KLA:

KLA Corporation ("KLA") develops industry-leading equipment and services that enable innovation throughout the electronics industry. We provide advanced process control and process-enabling solutions for manufacturing wafers and reticles, integrated circuits, packaging and printed circuit boards. In close collaboration with leading customers across the globe, our expert teams of physicists, engineers, data scientists and problem-solvers design solutions that move the world forward. Investors and others should note that KLA announces material financial information including SEC filings, press releases, public earnings calls and conference webcasts using an investor relations website (ir.kla.com). Additional information may be found at: www.kla.com

Note Regarding Forward-Looking Statements:
Statements in this press release other than historical facts, such as statements pertaining to total revenues, GAAP and non-GAAP gross margin and GAAP and non-GAAP diluted EPS for the quarter ending June 30, 2024, are forward-looking statements and are subject to the Safe Harbor provisions created by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current information and expectations and involve a number of risks and uncertainties. Actual results may differ materially from those projected in such statements due to various factors, including but not limited to: our vulnerability to a weakening in the condition of the financial markets and the global economy; risks related to our international operations; evolving Bureau of Industry and Security of the U.S. Department of Commerce rules and regulations and their impact on our ability to sell products to and provide services to certain customers in China; costly intellectual property disputes that could result in our inability to sell or use the challenged technology; risks related to the legal, regulatory and tax environments in which we conduct our business; increasing attention to ESG matters and the resulting costs, risks and impact on our business; unexpected delays, difficulties and expenses in executing against our environmental, climate, diversity and inclusion or other ESG targets, goals and commitments; our ability to attract, retain and motivate key personnel; our vulnerability to disruptions and delays at our third party service providers; cybersecurity threats, cyber incidents affecting our and our business partners' systems and networks; our inability to access critical information in a timely manner due to system failures; our ability to identify suitable acquisition targets and successfully integrate and manage acquired businesses; climate change, earthquake, flood or other natural catastrophic events, public health crises such as the COVID-19 pandemic or terrorism and the adverse impact on our business operations; the war between Ukraine and Russia, and the war between Israel and Hamas, and the significant military activity in that region; lack of insurance for losses and interruptions caused by terrorists and acts of war, and our self-insurance of certain risks including earthquake risk; risks related to fluctuations in foreign currency exchange rates; risks related to fluctuations in interest rates and the market values of our portfolio investments; risks related to tax and regulatory compliance audits; any change in taxation rules or practices and our effective tax rate; compliance costs with federal securities laws, rules, regulations, NASDAQ requirements, and evolving accounting standards and practices; ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns; our vulnerability to a highly concentrated customer base; the cyclicality of the industries in which we operate; our ability to timely develop new technologies and products that successfully address changes in the industry; our ability to maintain our technology advantage and protect proprietary rights; our ability to compete in the industry; availability and cost of the materials and parts used in the production of our products; our ability to operate our business in accordance with our business plan; risks related to our debt and leveraged capital structure; we may not be able to declare cash dividends at all or in any particular amount; liability to our customers under indemnification provisions if our products fail to operate properly or contain defects or our customers are sued by third parties due to our products; our government funding for R&D is subject to audit, and potential termination or penalties; we may incur significant restructuring charges or other asset impairment charges or inventory write offs; and risks related to receivables factoring arrangements and compliance risk of certain settlement agreements with the government. For other factors that may cause actual results to differ materially from those projected and anticipated in forward-looking statements in this press release, please refer to KLA's Annual Report on Form 10-K for the year ended June 30, 2023, and other subsequent filings with the Securities and Exchange Commission (including, but not limited to, the risk factors described therein). KLA assumes no obligation to, and does not currently intend to, update these forward-looking statements.

 

KLA Corporation




Condensed Consolidated Unaudited Balance Sheets








(In thousands)

March 31, 2024


June 30, 2023

ASSETS




Current assets:




Cash and cash equivalents

$             1,848,167


$             1,927,865

Marketable securities

2,446,135


1,315,294

Accounts receivable, net

1,625,257


1,753,361

Inventories

3,007,053


2,876,784

Other current assets

601,470


498,728

Total current assets

9,528,082


8,372,032

Land, property and equipment, net

1,106,278


1,031,841

Goodwill, net

2,015,727


2,278,820

Deferred income taxes

879,380


816,899

Purchased intangible assets, net

727,601


935,303

Other non-current assets

700,221


637,462

Total assets

$           14,957,289


$           14,072,357

LIABILITIES AND STOCKHOLDERS' EQUITY



Current liabilities:




Accounts payable

$                354,720


$                371,026

Deferred system revenue

994,469


651,720

Deferred service revenue

450,933


416,606

Current portion of long-term debt

749,889


?

Other current liabilities

1,908,527


2,303,490

Total current liabilities

4,458,538


3,742,842

Long-term debt

5,879,025


5,890,736

Deferred tax liabilities

480,270


529,287

Deferred service revenue

271,365


176,681

Other non-current liabilities

773,206


813,058

Total liabilities

11,862,404


11,152,604

Stockholders' equity:




Common stock and capital in excess of par value

2,177,501


2,107,663

Retained earnings

958,904


848,431

Accumulated other comprehensive loss

(41,520)


(36,341)

Total stockholders' equity

3,094,885


2,919,753

Total liabilities and stockholders' equity

$           14,957,289


$           14,072,357

 

KLA Corporation









Condensed Consolidated Unaudited Statements of Operations









Three Months Ended March 31,


Nine Months Ended March 31,

(In thousands, except per share amounts)


2024


2023


2024


2023

Revenues:









Product


$     1,769,369


$     1,903,484


$     5,527,842


$     6,562,501

Service


590,461


529,124


1,715,670


1,578,418

Total revenues


2,359,830


2,432,608


7,243,512


8,140,919

Costs and expenses:









Costs of revenues


993,885


1,005,346


2,917,522


3,255,358

Research and development


321,590


328,276


953,222


979,617

Selling, general and administrative


237,514


238,393


714,403


735,469

Impairment of goodwill and purchased intangible assets


70,474


?


289,474


?

Interest expense


79,981


74,774


228,417


223,449

Loss on extinguishment of debt


?


?


?


13,286

Other expense (income), net


(45,622)


(14,864)


(104,515)


(79,944)

Income before income taxes


702,008


800,683


2,244,989


3,013,684

Provision for income taxes


100,467


102,846


319,539


310,987

Net income


601,541


697,837


1,925,450


2,702,697

Less: Net income attributable to non-controlling interest


?


?


?


74

Net income attributable to KLA


$         601,541


$         697,837


$     1,925,450


$     2,702,623

Net income per share attributable to KLA









Basic


$               4.46


$               5.06


$             14.20


$             19.26

Diluted


$               4.43


$               5.03


$             14.11


$             19.16

Weighted-average number of shares:









Basic


134,954


137,865


135,638


140,349

Diluted


135,856


138,645


136,428


141,073

 

KLA Corporation




Condensed Consolidated Unaudited Statements of Cash Flows





Three Months Ended March 31,

(In thousands)

2024


2023

Cash flows from operating activities:




Net income

$               601,541


$               697,837

Adjustments to reconcile net income to net cash provided by operating activities:




Impairment of goodwill

70,474


?

Depreciation and amortization

99,263


104,854

Unrealized foreign exchange (gain) loss and other

7,629


(16,531)

Stock-based compensation expense

56,682


48,130

Deferred income taxes

11,886


(66,596)

Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:




Accounts receivable

194,311


342,090

Inventories

28,359


(211,216)

Other assets

(111,233)


(60,973)

Accounts payable

(10,238)


(119,606)

Deferred system revenue

110,442


(1,765)

Deferred service revenue

54,288


5,332

Other liabilities

(203,426)


289,299

Net cash provided by operating activities

909,978


1,010,855

Cash flows from investing activities:




Business acquisitions, net of cash acquired

(3,682)


?

Capital expenditures

(71,793)


(84,914)

Purchases of available-for-sale and equity securities

(1,172,264)


(402,672)

Proceeds from sale of available-for-sale securities

55,722


37,786

Proceeds from maturity of available-for-sale securities

342,808


345,972

Purchases of trading securities

(46,456)


(40,176)

Proceeds from sale of trading securities

37,619


30,797

Net cash used in investing activities

(858,046)


(113,207)

Cash flows from financing activities:




Proceeds from issuance of debt, net of issuance costs

735,043


?

Repayment of debt

?


(225,000)

Common stock repurchases

(372,251)


(478,186)

Payment of dividends to stockholders

(197,154)


(180,854)

Tax withholding payments related to vested and released restricted stock units

(24,274)


(16,154)

Contingent consideration payable and other, net

(2,440)


(2,527)

Net cash provided by (used in) financing activities

138,924


(902,721)

Effect of exchange rate changes on cash and cash equivalents

(7,743)


2,109

Net increase (decrease) in cash and cash equivalents

183,113


(2,964)

Cash and cash equivalents at beginning of period

1,665,054


1,571,477

Cash and cash equivalents at end of period

$            1,848,167


$            1,568,513

Supplemental cash flow disclosures:




Income taxes paid, net

$               159,848


$                 56,779

Interest paid

$               113,372


$               125,055

Non-cash activities:




Contingent consideration payable - financing activities

$                       ?


$                     (75)

Dividends payable - financing activities

$                  2,105


$                  1,915

Unsettled common stock repurchase - financing activities

$                 10,999


$                 15,943

Accrued purchase of land, property and equipment - investing activities

$                 15,378


$                 14,390

 

KLA Corporation
Segment Information (Unaudited)

The following is a summary of results for each of our three reportable segments and reconciliations to total revenues for the indicated periods:



Three Months Ended March 31,


Nine Months Ended March 31,

(In thousands)


2024


2023


2024


2023

Revenues:









Semiconductor Process Control


$     2,096,005


$     2,171,557


$     6,425,562


$     7,226,711

Specialty Semiconductor Process


130,649


128,438


407,433


414,390

PCB, Display and Component Inspection


133,399


131,923


412,474


502,627

Total revenues for reportable segments


2,360,053


2,431,918


7,245,469


8,143,728

Corporate allocations and effects of changes in
foreign currency exchange rates


(223)


690


(1,957)


(2,809)

Total revenues


$     2,359,830


$     2,432,608


$     7,243,512


$     8,140,919

 

KLA Corporation
Condensed Consolidated Unaudited Supplemental Information

Reconciliation of GAAP Net Income to Non-GAAP Net Income 




Three Months Ended


Nine Months Ended


(In thousands, except per share amounts)


March 31,
2024


Dec. 31,
2023


March 31,
2023


March 31,
2024


March 31,
2023

GAAP net income attributable to KLA


$      601,541


$      582,534


$      697,837


$  1,925,450


$  2,702,623

Adjustments to reconcile GAAP net income to
non-GAAP net income:












Acquisition-related charges

a

58,573


59,307


65,050


181,124


206,999


Restructuring, severance and other charges

b

2,042


1,270


19,089


3,312


13,900


Impairment of goodwill and purchased
intangible assets

c

70,474


219,000


?


289,474


?


Loss on extinguishment of debt

d

?


?


?


?


13,286


Income tax effect of non-GAAP adjustments

e

(19,879)


(22,806)


(22,942)


(63,084)


(69,517)


Discrete tax items

f

2,386


(103)


1,688


4,538


(52,277)

Non-GAAP net income attributable to KLA


$      715,137


$      839,202


$      760,722


$  2,340,814


$  2,815,014

GAAP net income per diluted share attributable
to KLA


$            4.43


$            4.28


$            5.03


$          14.11


$          19.16

Non-GAAP net income per diluted share
attributable to KLA


$            5.26


$            6.16


$            5.49


$          17.16


$          19.95

Shares used in diluted net income per share
calculation


135,856


136,254


138,645


136,428


141,073

 

Pre-tax Impact of GAAP to Non-GAAP Adjustments Included in Condensed Consolidated Unaudited Statements of Operations 

(In thousands)

Acquisition -
Related
Charges


Restructuring,
Severance and
Other Charges


Goodwill and
Purchased
Intangible
Asset
Impairment


Total Pre-tax GAAP
to Non-GAAP
Adjustments

Three Months Ended March 31, 2024








Costs of revenues

$        44,839


$              805


$                ?


$                45,644

Research and development

867


922


?


1,789

Selling, general and administrative

12,867


315


?


13,182

Impairment of goodwill

?


?


70,474


70,474

Total in three months ended March 31, 2024

$        58,573


$          2,042


$        70,474


$              131,089

Three Months Ended Dec. 31, 2023








Costs of revenues

$        46,078


$              467


$                ?


$                46,545

Research and development

?


417


?


417

Selling, general and administrative

13,229


386


?


13,615

Impairment of goodwill and purchased intangible assets

?


?


219,000


219,000

Total in three months ended Dec. 31, 2023

$        59,307


$          1,270


$      219,000


$              279,577

Three Months Ended March 31, 2023








Costs of revenues

$        45,437


$          6,039


$                ?


$                51,476

Research and development

?


6,664


?


6,664

Selling, general and administrative

19,613


6,386


?


25,999

Total in three months ended March 31, 2023

$        65,050


$        19,089


$                ?


$                84,139

 

Free Cash Flow Reconciliation 


Three Months Ended March 31,


Nine Months Ended March 31,

(In thousands)

2024


2023


2024


2023

Net cash provided by operating activities

$          909,978


$      1,010,855


$      2,415,960


$      2,710,690

Capital expenditures

(71,793)


(84,914)


(216,639)


(262,908)

Free cash flow

$          838,185


$          925,941


$      2,199,321


$      2,447,782

 

Capital Returns Calculation 


Three Months Ended March 31,


Nine Months Ended March 31,

(In thousands)

2024


2023


2024


2023

Payments of dividends to stockholders

$          197,154


$          180,854


$          575,520


$          553,046

Common stock repurchases

372,251


478,186


1,265,480


923,039

Capital returns

$          569,405


$          659,040


$      1,841,000


$      1,476,085

 

Fourth Quarter Fiscal 2024 Guidance

Reconciliation of GAAP Diluted EPS to Non-GAAP Diluted EPS



Three Months Ending June 30, 2024

(In millions, except per share amounts)


Low


High

GAAP net income per diluted share


$5.06


$6.26

Acquisition-related charges

a

0.44


0.44

Restructuring, severance and other charges

b

0.14


0.14

Income tax effect of non-GAAP adjustments

e

(0.17)


(0.17)

Non-GAAP net income per diluted share


$5.47


$6.67

Shares used in net income per diluted share calculation


135.4


135.4

 

Reconciliation of GAAP Gross Margin to Non-GAAP Gross Margin



Three Months Ending June 30, 2024



Low


High

GAAP gross margin


58.5 %


60.5 %

Acquisition-related charges

a

1.9 %


1.9 %

Restructuring, severance and other charges

b

0.1 %


0.1 %

Non-GAAP gross margin


60.5 %


62.5 %

 

The non-GAAP and supplemental information provided in this press release is a supplement to, and not a substitute for, KLA's financial results presented in accordance with United States GAAP.

To supplement our Condensed Consolidated Financial Statements presented in accordance with GAAP, we provide certain non-GAAP financial information, which is adjusted from results based on GAAP to exclude certain gains, costs and expenses, as well as other supplemental information. The non-GAAP and supplemental information is provided to enhance the user's overall understanding of our operating performance and our prospects in the future. Specifically, we believe that the non-GAAP information, including non-GAAP net income attributable to KLA, non-GAAP net income per diluted share attributable to KLA, non-GAAP gross margin and free cash flow, provides useful measures to both management and investors regarding financial and business trends relating to our financial performance by excluding certain costs and expenses that we believe are not indicative of our core operating results to help investors compare our operating performances with our results in prior periods as well as with the performance of other companies. The non-GAAP information is among the budgeting and planning tools that management uses for future forecasting. However, because there are no standardized or generally accepted definitions for most non-GAAP financial metrics, definitions of non-GAAP financial metrics are inherently subject to significant discretion (for example, determining which costs and expenses to exclude when calculating such a metric). As a result, non-GAAP financial metrics may be defined very differently from company to company, or even from period to period within the same company, which can potentially limit the usefulness of such information to an investor. The presentation of non-GAAP and supplemental information is not meant to be considered in isolation or as a substitute for results prepared and presented in accordance with United States GAAP. The following are descriptions of the adjustments made to reconcile GAAP net income attributable to KLA to non-GAAP net income attributable to KLA:

a.

Acquisition-related charges primarily include amortization of intangible assets, transaction costs associated with our acquisitions and dispositions, as well as intangible asset impairment charges. Although we exclude the effect of amortization of all acquired intangible assets from these non-GAAP financial measures, management believes that it is important for investors to understand that such intangible assets were recorded as part of purchase price accounting arising from acquisitions, and such amortization of intangible assets related to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Investors should note that the use of these intangible assets contributed to our revenues earned during the periods presented and are expected to contribute to our future period revenues as well.

b.

Restructuring, severance and other charges primarily include costs associated with employee severance including associated acceleration of recognition of certain stock-based and other compensation expenses, gains and losses from exiting non-core businesses and adjustments related to non-controlling interest. Restructuring, severance and other charges in the nine months ended March 31, 2023 included a gain on the sale of Orbograph, Ltd. ("Orbograph"), which was sold in the first quarter of fiscal 2023, partially offset by certain transaction bonuses triggered by the sale of Orbograph.

c.

Impairment of goodwill and purchased intangible assets included non-cash expense recognized in the three months ended March 31, 2024 and Dec. 31, 2023, following the downward revision of financial outlook for the PCB and Display reporting units in the second quarter of fiscal 2024 and the subsequent decision to exit the Company's Display business that was based on many factors, including the cancellation of a significant new technology project by a major customer, in the third quarter of fiscal 2024. Management believes that it is appropriate to exclude these impairment charges as they are not indicative of ongoing operating results and therefore limit comparability. Management also believes excluding this item helps investors compare our operating performance with our results in prior periods as well as with the performance of other companies.

d.

Loss on extinguishment of debt during the nine months ended March 31, 2023 included a pre-tax loss on early extinguishment of the $500 million 4.650% Senior Notes due in Nov. 2024.

e.

Income tax effect of non-GAAP adjustments includes the income tax effects of the excluded items noted above.

f.

Discrete tax items in the nine months ended March 31, 2024 included a one-time tax benefit resulting from changes made to our international structure to better align ownership of certain intellectual property rights with how our business operates. Discrete tax items in all periods presented included a tax impact relating to the amortization of the aforementioned tax benefit or similar tax benefits recorded in other periods. Discrete items in the nine months ended March 31, 2023 included an adjustment of the net benefit of the Orbotech Ltd. 2012 to 2018 Israel tax audit settlement, for which the net benefit includes the liability on the audit settlement less reductions in unrecognized tax positions and deferred tax assets and liabilities. Discrete tax items in the nine months ended March 31, 2023 also included a tax impact from the sale of Orbograph and a tax expense of $19.8 million from an internal restructuring.

 

SOURCE KLA Corporation


These press releases may also interest you

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...



News published on and distributed by: